Day: October 26, 2023

Conversion of preferred shares positions company for future investment opportunities Jacksonville, Fla., Oct. 26, 2023 (GLOBE NEWSWIRE) — Everything Blockchain Inc., (OTCMKTS: EBZT), a technology company that is blending blockchain, DBMS and Zero Trust to deliver disruptive new ways to store, manage and protect data, today announced that in preparation for future uplisting to a senior exchange, a number of the company’s major shareholders have begun converting their Series A and Series B Preferred Stock to common shares. The conversion of stocks positions EBI for broader investment exposure and helps paves the way for continued growth. Uplisting to a senior exchange will garner EBI greater opportunities for analyst coverage, and access to a larger network of high-level investment professionals who may be interested in the company....

IRVINE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”) is pleased to announce that the Company’s recent submission of Fexapotide Triflutate for the treatment of symptoms of benign prostate enlargement (benign prostatic hyperplasia, referred to as BPH) has been validated by the U.K. authorities, at U.K. Medicines & Healthcare products Regulatory Agency (MHRA). The formal review process has now started. The trademarked name for the new product is NYMOZARFEX (TM). The Marketing Authorization Application (MAA) was submitted September 25, 2023. The new submission includes England, Wales, Scotland and Northern Ireland. The Company will continue to provide further information, including other expected submissions, when the information becomes available. Paul Averback...

Los Angeles, CA., Oct. 26, 2023 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions, and systems developer, today announced the pricing of an underwritten offering of 6,400,000 common shares (or pre-funded warrants to purchase common shares in lieu thereof) and accompanying warrants to purchase up to 6,400,000 common shares. Each common share (or pre-funded warrant to purchase one common share) was sold together with one warrant at a combined public offering price of US$0.55, for gross proceeds of approximately US$3.5 million (the “Offering”), before deducting underwriting discounts and offering expenses. The warrants will have an exercise price of approximately US$0.61 per share, are exercisable immediately and will expire five...

NO CORRECTIONS in English version. The retail turnover (including VAT) of Apranga Group reached EUR 231.2 million in 9 months 2023 and increased by 10.7% comparing to corresponding period of 2022. The unaudited consolidated profit before income tax of Apranga Group amounted to EUR 15.8 million in the nine months of 2023. The Group made profit before income tax of EUR 13.5 million in the same period of 2022. EBITDA of Apranga Group reached EUR 31.0 million in the nine months 2023 and increased by 9.5% comparing to corresponding period of 2022. Considering the actual results, operational plans for 2023 were revised. The Group plans to reach EUR 323 million turnover (including VAT) in 2023, or by 10% higher than 2022 turnover. In 2023, the Group plans to renovate or open 20 stores. The net investment is planned to be about EUR 9 million. The...